IKNA
Price:
$1.69
Market Cap:
$81.56M
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts...[Read more]
Industry
Biotechnology
IPO Date
2021-03-26
Stock Exchange
NASDAQ
Ticker
IKNA
According to Ikena Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.22. This represents a change of 27.73% compared to the average of 14.26 of the last 4 quarters.
The mean historical Current Ratio of Ikena Oncology, Inc. over the last ten years is 7.22. The current 18.22 Current Ratio has changed 25.14% with respect to the historical average. Over the past ten years (40 quarters), IKNA's Current Ratio was at its highest in in the June 2024 quarter at 18.22. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
7.22
Median
6.65
Minimum
3.51
Maximum
12.58
Discovering the peaks and valleys of Ikena Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 69.02%
Maximum Annual Current Ratio = 12.58
Minimum Annual Increase = -32.88%
Minimum Annual Current Ratio = 3.51
Year | Current Ratio | Change |
---|---|---|
2023 | 12.58 | 69.02% |
2022 | 7.44 | -14.46% |
2021 | 8.70 | 48.50% |
2020 | 5.86 | 67.05% |
2019 | 3.51 | -32.88% |
The current Current Ratio of Ikena Oncology, Inc. (IKNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
9.57
5-year avg
7.62
10-year avg
7.22
Ikena Oncology, Inc.’s Current Ratio is less than Edgewise Therapeutics, Inc. (30.24), less than Design Therapeutics, Inc. (41.42), greater than Xilio Therapeutics, Inc. (2.02), less than Eliem Therapeutics, Inc. (60.41), greater than Monte Rosa Therapeutics, Inc. (6.56), greater than Werewolf Therapeutics, Inc. (12.13), greater than Stoke Therapeutics, Inc. (6.67), greater than Anebulo Pharmaceuticals, Inc. (5.32), greater than Celcuity Inc. (14.95), less than MediciNova, Inc. (18.24), greater than Rezolute, Inc. (11.82), greater than Aerovate Therapeutics, Inc. (6.51), greater than Decibel Therapeutics, Inc. (3.03), greater than Foghorn Therapeutics Inc. (5.69), greater than Shattuck Labs, Inc. (7.62), greater than Kymera Therapeutics, Inc. (8.45), greater than Nurix Therapeutics, Inc. (5.57),
Company | Current Ratio | Market cap |
---|---|---|
30.24 | $1.64B | |
41.42 | $264.42M | |
2.02 | $35.74M | |
60.41 | $495.57M | |
6.56 | $349.21M | |
12.13 | $88.28M | |
6.67 | $773.92M | |
5.32 | $46.68M | |
14.95 | $557.67M | |
18.24 | $103.00M | |
11.82 | $240.80M | |
6.51 | $54.85M | |
3.03 | $123.37M | |
5.69 | $416.63M | |
7.62 | $167.05M | |
8.45 | $2.89B | |
5.57 | $1.50B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ikena Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ikena Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Ikena Oncology, Inc.'s Current Ratio?
How is the Current Ratio calculated for Ikena Oncology, Inc. (IKNA)?
What is the highest Current Ratio for Ikena Oncology, Inc. (IKNA)?
What is the 3-year average Current Ratio for Ikena Oncology, Inc. (IKNA)?
What is the 5-year average Current Ratio for Ikena Oncology, Inc. (IKNA)?
How does the current Current Ratio for Ikena Oncology, Inc. (IKNA) compare to its historical average?